<DOC>
	<DOCNO>NCT01674595</DOCNO>
	<brief_summary>This trial open , national , multi-centre trial . The trial initiate olive pollen season 2012 subject receive treatment 6 week . The aim study assess tolerability up-dosing phase AVANZ Olive . The frequency patient adverse reaction primary endpoint . Frequency patient systemic reaction accord EAACI classification , increase IgG4 IgE reduction immediate skin reactivity .</brief_summary>
	<brief_title>An Open Trial Assess Tolerability AVANZ Olive Immunotherapy</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<criteria>1 . Male female patient 1865 year age . 2 . A clinical history olive pollen induce allergic rhinoconjunctivitis without asthma least one year prior trial entry . 3 . Positive SPT olive pollen ( wheal diameter ≥ 3 mm ) . 4 . A positive specific IgE olive pollen ( ≥Class 2 ; ≥0.70 KU/L ) document last 5 1 . FEV1 &lt; 70 % predict value screen adequate pharmacologic treatment . 2 . Uncontrolled severe asthma . 3 . A clinically relevant history symptomatic perennial allergic rhinitis and/or conjunctivitis cause allergen subject regularly expose sensitize . 4 . History severe asthma exacerbation emergency room visit admission asthma previous 12 month . 5 . At screen , current symptom , treatment , upper respiratory tract infection , acute sinusitis , acute otitis medium relevant infection ( serous otitis medium exclusion criterion ) . 6 . Treatment parenteral corticosteroid , oral corticosteroid antiIgE previous 3 month study ( except steroid need rescue medication ) . 7 . Currently treat angiotensin convert enzyme ( ACE ) inhibitor , tricyclic antidepressant , βblockers , mono amine oxidase inhibitor ( MAOIs ) drug contain alum ( e.g . antacid ) take daily basis . 8 . Previous treatment allergen concomitant IT immunotherapy Olea europaea extract within previous 5 year ( initiation subcutaneous immunotherapy acceptable treatment discontinue reach maintenance dose ; SLIT 3 month last 5 year accept ) . 9 . History anaphylactic shock due e.g . food , insect venom , exercise drug . 10 . History severe recurrent angioedema . 11 . Any contraindication accord Investigator Brochure ( IB ) . 12 . Use investigational drug within 30 day prior screen .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Olea sensitization</keyword>
</DOC>